Literature DB >> 3601270

Treatment of vaginal condylomata acuminata by weekly topical application of 5-fluorouracil.

H B Krebs.   

Abstract

Twenty nonpregnant women with condylomata acuminata of the vagina were studied to assess the effectiveness of weekly topical 5-fluorouracil application. All patients were instructed to insert an applicator one-third full of 5% 5-fluorouracil cream (approximately 1.5 g) deeply into the vagina at bedtime once each week for ten consecutive weeks. The response to this treatment was evaluated by colposcopy and cytology three and six months after initiation of therapy. Seventeen patients (85%) showed no evidence of the disease when examined three months after treatment. Three women, although improved, had persistent vaginal condylomata, which responded to a second course of 5-fluorouracil given twice each week. After a follow-up of ten to 20 months (mean 15.8 months), 16 patients remained free of disease, two developed recurrence, and two were lost to follow-up. Two women developed mild vulvar irritation and eight had vaginal discharge. It is concluded that weekly topical application of 5% 5-fluorouracil is well tolerated and highly effective in treating vaginal condylomata acuminata.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3601270

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  4 in total

Review 1.  5-FU for genital warts in non-immunocompromised individuals.

Authors:  Claudio S Batista; Alvaro N Atallah; Humberto Saconato; Edina Mk da Silva
Journal:  Cochrane Database Syst Rev       Date:  2010-04-14

2.  Papillomaviral Infections of the Female Genital Tract: A look at the full spectrum of HPV infections.

Authors:  M G Munro
Journal:  Can Fam Physician       Date:  1992-11       Impact factor: 3.275

3.  Topical therapies for the treatment of anal high-grade squamous intraepithelial lesions.

Authors:  Christina Megill; Timothy Wilkin
Journal:  Semin Colon Rectal Surg       Date:  2017-04-26

4.  A randomized, double-blind, placebo-controlled trial of 5-fluorouracil for the treatment of cervicovaginal human papillomavirus.

Authors:  M M Holmes; S H Weaver; S T Vermillion
Journal:  Infect Dis Obstet Gynecol       Date:  1999
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.